However, while RAS levels were lower than BD and HCs there was no significant differences between patient groups and HCs, therefore, IL-4 may be a more prominent force driving the production of antibodies in the mouth other than systemically driving a Th2 response. The gene discussed is IL4; the disease is Behcet disease.